Ynsect is a biotech company that designs, builds, and operates insect production and processing facilities for the production of feed for fish and poultry.

Ynsect's main activities include the bioconversion of organic resources by insects, and their processing into nutrients for feed applications (proteins, lipids, and others) and non-food applications (polysaccharides and derivatives, organic fertilizers, bioenergy, and others).

Ynsect was founded in 2011 & is based in Paris, France, it also has an office in Jura, France.

Ÿnsect builds state-of-the-art industrial facilities attuned to natural ecosystems, offering an organic, long-term solution to booming global demand for protein.

Ÿnsect draws on pioneering proprietary technology protected by 29 patents to develop its vertical farms (Fermilières®), which are ultra low-footprint vertical farms used for Molitor production. Ynsect offers Protein-Rich Insect Material, a nutritional product that is a mix of proteins and bioactive molecules to improve fish growth and survivability.


Ynsect is backed by Bpifrance, European Commission, Future Positive Capital, Upfront Ventures, FootPrint Coalition, Astanor Ventures, & Talis Capital among others. The company raised $224M (($139M in debt and another $65M in equity) in further financing, bringing its Series C round to $372M. This additional investment brings Ynsect's total funding to $376.3M to date.



  • Year founded: 2011
  • Funding Info: $376.3M over 9 Rounds (Latest Funding Type: Venture- Series Unknown)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Evry
  • State: Ile-de-France
  • Country: France
Related businesses